Clinical Trial Update: Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis

View source ↗

Summary

A completed clinical trial evaluating etanercept (Enbrel) in patients with Ankylosing Spondylitis; sponsor Wyeth is now a subsidiary of Pfizer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Ankylosing Spondylitis | Status: COMPLETED